Trial intelligence / Profile preview

Marvelon in Iranian Women with PMS

NCT01256619Phase 2Unknown

Sponsor
Tehran University of Medical Sciences
Start
Sep 2010
Primary completion
Sep 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of desogestrel in premenstrual syndrome (PMS), sponsored by Tehran University of Medical Sciences. Primary endpoint: Serum Lipids at 6 months. Status: unknown.

02

Drugs

desogestrel
03

Conditions

premenstrual syndrome (PMS)

Beyond the preview

Go deeper on NCT01256619.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01256619.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call